Ability of strains X3-2B and 37X-3 to inhibit xanthine oxidase in vitro and their mitigating effect on hyperuricemia in mice

  • WANG Shiqi ,
  • ZHANG Meizhi ,
  • HAO Shiqi ,
  • LI Jiarang ,
  • LI Xiaotong ,
  • WANG Furong ,
  • SUN Xueying ,
  • GE Yali ,
  • ZHAO Lihua
Expand
  • 1(Inner Mongolia Agricultural University, Hohhot 010020, China)
    2(College of Vocational and Technical, Inner Mongolia Agricultural University, Baotou 014000, China)
    3(Baotou Dongbao Bio-Tech Co., Ltd., Baotou 014000, China)

Received date: 2023-11-06

  Revised date: 2024-01-13

  Online published: 2024-11-01

Abstract

To investigate the inhibitory ability of strains X3-2B and 37X-3 on xanthine oxidase(XOD)and their alleviating effect on hyperuricemia (HUA) in mice, this study used HPLC to determine the content of xanthine and uric acid (UA) in the medium.The strains were cultured in a medium containing xanthine and XOD for different durations (20, 40, 60, 80 and 100 min).This study also adjusted the pH and bile salt concentration of the medium to study the inhibitory ability of XOD and the acid and alkali resistance of strains X3-2B and 37X-3 in vitro.In addition, sixty KM mice were divided into five groups, including control group (Group C), model group (Group M), X3-2B group (Group X), 37X-3 group (Group L), and allopurinol group (Group P).All groups, except for Group C, were fed high-purine chow.The mice were fed for 4 weeks, and the corresponding doses of strains X3-2B, 37X-3, and allopurinol were administered to groups X, L, and P respectively.This study investigated the mitigating effects of strains X3-2B and 37X-3 on HUA in mice by analyzing physiological and biochemical indexes, renal pathology sections, and intestinal tissues of the mice for XOD activity.Results showed that strains X3-2B and 37X-3 effectively inhibited XOD-catalyzed xanthine production of UA.At pH 2 and bile salt addition of 0.3%, the viable bacterial counts of X3-2B and 37X-3 were 6.4×107 CFU/g (X3-2B), 9.3×107 CFU/g (37X-3), and 2.1×106 CFU/g (X3-2B), 2.8×106 CFU/g (37X-3) respectively.After four weeks of feeding, there was a significant decrease in serum levels of UA, BUN, and Cr in mice in groups X and L (P<0.05).The renal units were structurally intact, and the activity of XOD in intestinal tissues was inhibited (P<0.05).The study concluded that strains X3-2B and 37X-3 were able to effectively inhibit XOD activity and reduce UA production.Furthermore, these strains were found to exert XOD inhibition function in the intestinal tract of HUA mice and alleviate HUA in mice.

Cite this article

WANG Shiqi , ZHANG Meizhi , HAO Shiqi , LI Jiarang , LI Xiaotong , WANG Furong , SUN Xueying , GE Yali , ZHAO Lihua . Ability of strains X3-2B and 37X-3 to inhibit xanthine oxidase in vitro and their mitigating effect on hyperuricemia in mice[J]. Food and Fermentation Industries, 2024 , 50(20) : 145 -152 . DOI: 10.13995/j.cnki.11-1802/ts.037878

References

[1] 崔佳佳. 尿酸盐晶体形态学及果糖对尿酸转运子影响的研究[D].泰安:泰山医学院, 2010.
CUI J J.Study of the morphological changes of urate ctystals and effect of fructose to the urate transporter[D].Taian:Taishan Medical University, 2010.
[2] WANG Z, CUI T, CI X Y, et al.The effect of polymorphism of uric acid transporters on uric acid transport[J].Journal of Nephrology, 2019, 32(2):177-187.
[3] 蓝淑珍, 周恩超.高尿酸血症对慢性肾脏病影响的研究进展[J].中国临床新医学, 2022, 15(9):878-882.
LAN S Z, ZHOU E C.Research progress in the effect of hyperuricemia on chronic kidney disease[J].Chinese Journal of New Clinical Medicine, 2022, 15(9):878-882.
[4] HUANG J Y, MA Z F, ZHANG Y T, et al.Geographical distribution of hyperuricemia in mainland China:A comprehensive systematic review and meta-analysis[J].Gloabl Health Research and Policy, 2020, 5(1):52-52.
[5] BOHATÁ J, HORVÁTHOVÁ V, PAVLÍKOVÁ M, Et al.Circulating microRNA alternations in primary hyperuricemia and gout[J].Arthritis Research & Therapy, 2021, 23(1):186.
[6] RUAN F K, LIU C Q, HU W P, et al.Early life PCB138 exposure induces kidney injury secondary to hyperuricemia in male mice[J].Environmental Pollution, 2022, 301:118977.
[7] LI Y K, LI H Q, WANG R, et al.Protective effect of sodium butyrate on intestinal barrier damage and uric acid reduction in hyperuricemia mice[J].Biomedicine & Pharmacotherapy, 2023, 161:114568.
[8] WANG F Q, ZHAO X, SU X, et al.Isorhamnetin, the xanthine oxidase inhibitor from Sophora japonica, ameliorates uric acid levels and renal function in hyperuricemic mice[J].Food & Function, 2021, 12(24):12503-12512.
[9] DALBETH N, CHOI H K, JOOSTEN L A B, et al.Gout[J].Nature Reviews Disease Primers, 2019, 5:69.
[10] LIU X P, ZHANG Z J, ZHANG Y, et al.Artificial metalloenzyme-based enzyme replacement therapy for the treatment of hyperuricemia[J].Advanced Functional Materials, 2016, 26(43):7921-7928.
[11] ZHANG L, ZHANG C, ZHUANG Z N, et al.Bio-inspired nanoenzyme for metabolic reprogramming and anti-inflammatory treatment of hyperuricemia and gout[J].Science China Chemistry, 2021, 64(4):616-628.
[12] 张丽萍, 杨建雄.生物化学简明教程[M].北京:高等教育出版社, 2015.
ZHANG L P, YANG J X.A Concise Course in Biochemistry[M].Beijing:Higher Education Press, 2015.
[13] DA SILVA T F, CASAROTTI S N, DE OLIVEIRA G L V, et al.The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts[J].Critical Reviews in Food Science and Nutrition, 2021, 61(2):337-355.
[14] OAK S J, JHA R.The effects of probiotics in lactose intolerance:A systematic review[J].Critical Reviews in Food Science and Nutrition, 2019, 59(11):1675-1683.
[15] LIANG X, LV Y Y, ZHANG Z, et al.Study on intestinal survival and cholesterol metabolism of probiotics[J].LWT, 2020, 124:109132.
[16] JOHNSTON B C, GOLDENBERG J Z, PARKIN P C, et al.Probiotics and the prevention of antibiotic-associated diarrhea in infants and children[J].JAMA, 2016, 316(14):1484-1485.
[17] WANG H, LEE I-S, BRAUN C, et al.Effect of probiotics on central nervous system functions in animals and humans:A systematic review[J].Journal of Neuroga stroenterology and Motility, 2016, 22(4):589-605.
[18] DING S J, HU C, FANG J, et al.The protective role of probiotics against colorectal cancer[J].Oxidative Medicine and Cellular Longevity, 2020, 2020(1):8884583.
[19] SEHRAWAT N, YADAV M, SINGH M, et al.Probiotics in microbiome ecological balance providing a therapeutic window against cancer[J].Seminars in Cancer Biology, 2021, 70:24-36.
[20] CAO J Y, WANG T, LIU Y S, et al.Lactobacillus fermentum F40-4 ameliorates hyperuricemia by modulating the gut microbiota and alleviating inflammation in mice[J].Food & Function, 2023, 14(7):3259-3268.
[21] MEI Z J, LI D D.The role of probiotics in vaginal health[J].Frontiers in Cellular and Infection Microbiology, 2022, 12:963868.
[22] RAWAL S, ALI S A.Probiotics and postbiotics play a role in maintaining dermal health[J].Food & Function, 2023, 14(9):3966-3981.
[23] YAMADA N, IWAMOTO C, KANO H, et al.Evaluation of purine utilization by Lactobacillus gasseri strains with potential to decrease the absorption of food-derived purines in the human intestine[J].Nucleosides, Nucleotides & Nucleic Acids, 2016, 35(10-12):670-676.
[24] XIAO Y X, ZHANG C X, ZENG X L, et al.Microecological treatment of hyperuricemia using Lactobacillus from pickles[J].BMC Microbiology, 2020, 20(1):195.
[25] 倪彩新. 乳杆菌对高尿酸血症的影响及作用途径探究[D].无锡:江南大学, 2021.
NI C X.Study of the effects and approaches of Lactobacillus on hyperuricaemia alleviation[D].Wuxi:Jiangnan University, 2021.
[26] 刘慧敏. 乳酸菌嘌呤降解菌株的筛选、基因组特征及其应用研究[D].扬州:扬州大学, 2021.
LIU H M.Screening, genomic characteristics and application of purine degrading lactic acid bacteria[D]. Yangzhou:Yangzhou University, 2021.
[27] ZHANG X P, WANG J J, WU Q H, et al.Determination of kanamycin by high performance liquid chromatography[J].Molecules, 2019, 24(10):1902.
[28] WIJEMANNE N, SOYSA P, WIJESUNDARA S, et al.Development and validation of a simple high performance liquid chromatography/UV method for simultaneous determination of urinary uric acid, hypoxanthine, and creatinine in human urine[J].International Journal of Analytical Chemistry, 2018, 2018:1647923.
[29] JIANG S Y, SONG D N, ZHAO H H, et al.Bioactivity and component analysis of water extract of Sophora japonica against hyperuricemia by inhibiting xanthine oxidase activity[J].Foods, 2022, 11(23):3772.
[30] EBEFORS K, BERGWALL L, NYSTRÖM J.The Glomerulus according to the mesangium[J].Frontiers in Medicine, 2022, 8:740527.
[31] PENG R, LIU K, LI W D, et al.Blood urea nitrogen, blood urea nitrogen to creatinine ratio and incident stroke:The Dongfeng-Tongji cohort[J].Atherosclerosis, 2021, 333:1-8.
[32] WANG S, WANG F, WANG X, et al.Elevated creatinine clearance in lupus nephritis patients with normal creatinine[J].International Journal of Medical Sciences, 2021, 18(6):1449-1455.
[33] SUN X W, WEN J, GUAN B S, et al.Folic acid and zinc improve hyperuricemia by altering the gut microbiota of rats with high-purine diet-induced hyperuricemia[J].Frontiers in Microbiology, 2022, 13:907952.
[34] DHOUIBI R, AFFES H, SALEM M B, et al.Creation of an adequate animal model of hyperuricemia (acute and chronic hyperuricemia);study of its reversibility and its maintenance[J].Life Sciences, 2021, 268:118998.
[35] BHOLE V, CHOI J W J, KIM S W, et al.Serum uric acid levels and the risk of type 2 diabetes:A prospective study[J].The American Journal of Medicine, 2010, 123(10):957-961.
[36] 杨殿斌.降血尿酸乳酸菌筛选及乳杆菌对高血尿酸血症大鼠作用的研究[D].大连:大连医科大学, 2013.
YANG D B.The screening of lactobacillus reduced blood uric acid and lactobacillus′ effect in hyperuricemia rat model[D].Dalian:Dalian Medical University, 2013.
[37] 邓英. 乳杆菌对高果糖诱导小鼠高尿酸血症的防治作用及机制探讨[D].大连:大连医科大学, 2018.
DENG Y.Prevention and cure effects of Lactobacillus on hyperuricemia induced by high fructose diet and its mechanism[D].Dalian:Dalian Medical University, 2018.
[38] OOI K L, ZAKARIA R, TAN M L, et al.The influence of chemical composition of potent inhibitors in the hydrolyzed extracts of anti-hyperuricemic plants to their xanthine oxidase activities[J].Journal of ethnopharmacology, 2021, 278:114-294.
Outlines

/